Showing results (871-880 of 905) with videos related to

Sort By:
Pageof 91
Swiss Medical Weekly|June 27, 2022
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort studyBabette L Winter, Frédérique Hovaguimian, Roger D Kouyos, et al.
Science (New York, N.Y.)|August 18, 2022
GPNMB confers risk for Parkinson's disease through interaction with α-synucleinMaria E Diaz-Ortiz, Yunji Seo, Marijan Posavi, et al.
BMC Public Health|September 7, 2024
Prevalence of Methamphetamine (Mkpurummiri) use in south east Nigeria: a community-based cross-sectional studyNkiru Edith Obande-Ogbuinya, Christian Okechukwu Aleke, Lois Nnenna Omaka-Amari, et al.
Discover Oncology|March 18, 2025
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefitToshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, et al.
Journal of Medicinal Chemistry|March 14, 2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2)Ilaria Peretto, Claudia Fossati, Giuseppe A M Giardina, et al.
HIV Medicine|October 4, 2021
Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collectionF Hovaguimian, E Martin, M Reinacher, et al.
Cancer Cell|August 25, 2023
KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cellsKrishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu, et al.
Journal of Medicinal Chemistry|March 14, 2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1)Ilaria Peretto, Roberto Forlani, Claudia Fossati, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 25, 2024
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in miceEiji Funayama, Masahiro Hosonuma, Kohei Tajima, et al.
Respiration; International Review of Thoracic Diseases|April 6, 2025
Predictive Factors of Clinical Success of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction: Results from the EpiGETIF RegistryPascalin Roy, Lyria Amari, Sophie Laroumagne, et al.
Pageof 91